Compare CDW & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDW | FMS |
|---|---|---|
| Founded | 1984 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Catalog/Specialty Distribution | Misc Health and Biotechnology Services |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 14.2B |
| IPO Year | 2013 | N/A |
| Metric | CDW | FMS |
|---|---|---|
| Price | $136.94 | $23.17 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 8 | 2 |
| Target Price | ★ $164.88 | $30.00 |
| AVG Volume (30 Days) | ★ 1.3M | 436.8K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | 1.88% | ★ 2.44% |
| EPS Growth | ★ 1.38 | N/A |
| EPS | ★ 8.08 | N/A |
| Revenue | ★ $10,768,600,000.00 | N/A |
| Revenue This Year | $4.08 | N/A |
| Revenue Next Year | $4.01 | $3.83 |
| P/E Ratio | $16.57 | ★ $15.62 |
| Revenue Growth | ★ 6.32 | N/A |
| 52 Week Low | $112.98 | $20.96 |
| 52 Week High | $189.45 | $30.46 |
| Indicator | CDW | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 72.83 | 52.96 |
| Support Level | $137.08 | $22.50 |
| Resistance Level | $150.48 | $23.36 |
| Average True Range (ATR) | 3.20 | 0.38 |
| MACD | 1.53 | 0.06 |
| Stochastic Oscillator | 100.00 | 64.29 |
CDW Corp is a multi-brand provider of information technology (IT) solutions to businesses, government, education, and healthcare customers in the United States, the United Kingdom, and Canada. The company's offerings range from hardware and software products to integrated IT solutions and services, including on-premise and cloud capabilities across hybrid infrastructure, digital experience, and security. Its reportable segments are Corporate, Small Business, Public, and Other. The Corporate and Small Business segments serve US private sector business customers, while the Public segment consists of government agencies and education and healthcare institutions in the US. The Corporate segment generates the majority of its revenue in the United States.
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.